Compass Therapeutics, Inc. — Cash Flow Charts
11 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+4.9% +$680K
$-13M
Free Cash Flow
$0
Investing Cash Flow↑+382.7% +$16M
$12M
Financing Cash Flow
$1M
Capex
$0
Acquisitions
—
Stock-Based Comp↓-18.5% -$413K
$2M
Debt Issued
—
Debt Repaid
—
D&A↓-87.9% -$123K
$17K
SBC Allocated Expense↓-18.5% -$413K
$2M
SBC Unrecognized Cost↑+28.4% +$6M
$28M